1. EURORDIS. European Organization for Rare Diseases. Rare diseases: understanding this public health priority. European Organization for Rare Diseases Web site. 2005.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736–55.
3. Spagnolo P, Cullinan P, du Bois RM. Sarcoidosis. In: King Jr TE, Schwarz MI, editors. Interstitial lung disease. Shelton: People’s Medical Publishing House-USA; 2011. p. 433–97.
4. Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990;323:1254–60.
5. Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995;151(2 Pt 1):527–33.